Intrinsiqq
Bioforce Nanosciences Holdings Inc. logo

Bioforce Nanosciences Holdings Inc. Financials

BFNH

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 10 available years
Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
~1.8:1 split
Revenues
Revenue$0–––––
Cost of Revenue$0–––––
Gross Profit$0–––––
General & Administrative$0$0$0$0$0$0
Total Operating Expenses$0$0$0$0$0$1
Operating Income-$0–––––
EBT (Earnings Before Tax)-$0-$0-$0–––
Net Income
Net Income-$0-$1-$0-$0-$0-$1
Per Share Data
Revenue Per Share$0.00–––––
EPS (Basic)-$0.00-$0.04-$0.02-$0.02-$0.02-$0.02
EPS (Diluted)-$0.00-$0.04-$0.02-$0.02-$0.02-$0.02
Weighted Avg Shares (Basic)15.3M33.2M29.3M29.3M29.3M29.3M
Weighted Avg Shares (Diluted)15.3M33.2M29.3M29.3M29.3M29.3M
Shares Outstanding15.3M33.2M29.3M29.3M29.3M29.3M

Bioforce Nanosciences Holdings (BFNH) financials: revenue, profit and margins

Bioforce Nanosciences Holdings (BFNH) generated about n/a in revenue and -$323,207.00 in net income over the trailing twelve months, growing at roughly 98.7% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Bioforce Nanosciences Holdings profitable?+

Bioforce Nanosciences Holdings reported about -$323,207.00 in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How fast is Bioforce Nanosciences Holdings growing?+

Bioforce Nanosciences Holdings's revenue has compounded at roughly 98.7% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside BFNH's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 9 Nov 2026, covering the period ending 31 Dec 2026, as reported to the SEC. Data last refreshed 12 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Laboratory Analytical Instruments · Pick stocks to compare with BFNH

CompareIntrinsic value
YBGJYubo International Biotech Limited
$0.01+0.00%10
NVNOEnVVeno Medical Corporation
$5.25-5.75%10
STMEStimcell Energetics Inc.
$0.24+0.00%0
DRORDror Ortho-Design Inc.
$0.00+0.00%40
ODYYOdyssey Group International Inc.
$0.01-7.14%10
HCILHongchang International Co. Ltd.
$0.00+0.00%10
RDGLVivos Inc.
$0.04-2.68%40
PAVMPAVmed Inc.
$1.14-5.42%35

Spot a number that looks wrong? Check it in BFNH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BFNH

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.